Cipla Stock Forecast for 2023 - 2025 - 2030

Updated on 03/27/2024

Stock Rating
18
Price Target
Rp1.48k
Consensus
Outperform
Downside
-1.93%
Analysts
32
Stock Rating
18
Downside
-1.93%
Analysts
32
Price Target
Rp1.48k

Cipla Stock Forecast and Price Target

The average price target for Cipla's stock of Rp1475.00 recently provided by thirty two leading analysts would represent a -1.93% downside from its last closing price if reached. This potential increase is based on a high estimate of Rp1750.00 and a low estimate of Rp1029.00. If you're thinking of investing in CIPLA stock, it's critical to check out its competitors as well.

Rp1.48k

-1.93% Downside

Outperform
Outperform

Cipla Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Cipla's Price has grown by 89.35%, rising from Rp538.78 to Rp1020.19. For the next year, analysts predict that Fair Value will reach Rp1368.60 – an increase of 34.15%. Over the next seven years, experts believe that Cipla's Fair Value will grow at a rate of 75.06%.

2024 Fair Value Forecast
Rp1.37k
2025 Fair Value Forecast
Rp1.52k
2026 Fair Value Forecast
Rp1.69k
2027 Fair Value Forecast
Rp1.79k
2028 Fair Value Forecast
Rp2.00k
2029 Fair Value Forecast
Rp1.83k
2030 Fair Value Forecast
Rp1.79k
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$734.37 Buy/Sell $636.99 10.71%
MRK Stock Forecast Merck Outperform 2
$122.77 Buy/Sell $130.51 9.96%
ABT Stock Forecast Abbott Laboratories Outperform 9
$120.19 Buy/Sell $118.92 4.83%
NOVN Stock Forecast Novartis Outperform 10
CHF88.80 Buy/Sell CHF105.00 23.95%
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%

Cipla Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Cipla's Revenue has grown by 32.08%, rising from Rp170.81B to Rp225.59B. For the next year, analysts predict that Revenue will reach Rp257.06B – an increase of 13.95%. Over the next seven years, experts believe that Cipla's Revenue will grow at a rate of 33.57%.

2024 Rev Forecast
Rp257.06B
2025 Rev Forecast
Rp281.59B
2026 Rev Forecast
Rp306.59B
2027 Rev Forecast
Rp331.64B
2028 Rev Forecast
Rp304.66B
2029 Rev Forecast
Rp297.71B
2030 Rev Forecast
Rp301.32B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SAN Stock Forecast Sanofi Outperform 16
88.32€ Buy/Sell 102.80€ 21.15%
ZTS Stock Forecast Zoetis Outperform 18
$183.49 Buy/Sell $220.47 20.72%
SUNPHARMA Stock Forecast Sun Pharmaceutical Industries Outperform 8
Rp1.59k Buy/Sell Rp1.52k -1.42%

Cipla Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Cipla's Dividend per Share has grown, moving from Rp3.00 to Rp8.50 – an increase of 183.33%. For the following year, the 28 analysts predict that Cipla's Dividend per Share will drop by 9.06%, reaching Rp7.73. Looking ahead to seven years, experts forecast that Dividend per Share will grow by 5.49%.

2024 DPS Forecast
Rp7.73
2025 DPS Forecast
Rp8.55
2026 DPS Forecast
Rp9.55
2027 DPS Forecast
Rp9.23
2028 DPS Forecast
Rp8.72
2029 DPS Forecast
Rp8.69
2030 DPS Forecast
Rp8.97
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAYN Stock Forecast Bayer Hold 5
26.82€ Buy/Sell 45.15€ 26.77%
TEVA Stock Forecast Teva Pharmaceutical Industries Outperform 12
$13.35 Buy/Sell $11.59 19.85%
VTRS Stock Forecast Viatris Inc Hold 8
$11.97 Buy/Sell $11.73 0.25%

Cipla Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
Rp30.75B
2025 FCF Forecast
Rp36.68B
2026 FCF Forecast
Rp41.37B
2027 FCF Forecast
Rp41.16B
2028 FCF Forecast
Rp37.46B
2029 FCF Forecast
Rp37.34B
2030 FCF Forecast
Rp38.67B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
500124 Stock Forecast Dr. Reddy's Laboratories Hold 18
Rp6.38k Buy/Sell Rp5.67k -6.20%
DIVISLAB Stock Forecast Divi's Laboratories Underperform 18
Rp3.60k Buy/Sell Rp3.30k -7.55%
DABUR Stock Forecast Dabur India Outperform 18
Rp533.40 Buy/Sell Rp607.25 13.42%

Cipla EBITDA Forecast for 2023 - 2025 - 2030

Cipla's EBITDA has seen growth In the last three years, going from Rp30.79B to Rp49.19B – a gain of 59.77% In the next year, analysts believe that EBITDA will reach Rp61.10B – an increase of 24.21%. For the next seven years, the forecast is forEBITDA to grow by 44.65%.

2024 EBITDA Forecast
Rp61.10B
2025 EBITDA Forecast
Rp67.91B
2026 EBITDA Forecast
Rp73.91B
2027 EBITDA Forecast
Rp75.59B
2028 EBITDA Forecast
Rp70.46B
2029 EBITDA Forecast
Rp69.74B
2030 EBITDA Forecast
Rp71.15B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
500420 Stock Forecast Torrent Pharmaceuticals Outperform 18
Rp2.70k Buy/Sell Rp2.13k 3.82%
IPN Stock Forecast Ipsen Outperform 17
106.40€ Buy/Sell 127.95€ 9.96%
500257 Stock Forecast Lupin Hold 12
Rp1.67k Buy/Sell Rp1.11k -8.05%

Cipla EBIT Forecast for 2023 - 2025 - 2030

In the last three years, EBIT for Cipla has grown by 89.05%, going from Rp21.20B to Rp40.08B. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach Rp50.20B – an increase of 25.25%. Over the next seven years, experts anticipate that EBIT growth for Cipla will be 46.73%.

2024 EBIT Forecast
Rp50.20B
2025 EBIT Forecast
Rp56.14B
2026 EBIT Forecast
Rp61.06B
2027 EBIT Forecast
Rp62.63B
2028 EBIT Forecast
Rp58.22B
2029 EBIT Forecast
Rp57.64B
2030 EBIT Forecast
Rp58.80B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
503806 Stock Forecast SRF Outperform 17
Rp2.46k Buy/Sell Rp2.48k 4.77%
ELAN Stock Forecast Elanco Animal Health Outperform 13
$16.02 Buy/Sell $14.90 12.36%
500488 Stock Forecast Abbott India Outperform 18
Rp27.23k Buy/Sell Rp24.75k 5.19%

Cipla EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Cipla's EPS has grown by 89.35%, rising from Rp19.16 to Rp36.28. For the next year, analysts predict that EPS will reach Rp48.67 – an increase of 34.15%. Over the next seven years, experts believe that Cipla's EPS will grow at a rate of 75.06%.

2024 EPS Forecast
Rp48.67
2025 EPS Forecast
Rp54.08
2026 EPS Forecast
Rp60.10
2027 EPS Forecast
Rp63.50
2028 EPS Forecast
Rp71.10
2029 EPS Forecast
Rp64.92
2030 EPS Forecast
Rp63.51
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AUROPHARMA Stock Forecast Aurobindo Pharma Outperform 18
Rp1.06k Buy/Sell Rp1.09k 10.08%
500660 Stock Forecast GlaxoSmithKline Pharmaceutical... Hold 18
Rp2.01k Buy/Sell Rp1.78k 5.21%
BIOCON Stock Forecast Biocon Hold 14
Rp279.20 Buy/Sell Rp270.86 2.08%